Evidence map›Paper›PMID 32235247›Full record

ArticleThe Pediatric infectious disease journal2020

Paradoxical Antibiotic Effect of Ampicillin: Use of a Population Pharmacokinetic Model to Evaluate a Clinical Correlate of the Eagle Effect in Infants With Bacteremia.

Jessica E Ericson, Christoph P Hornik, Rachel G Greenberg, Reese H Clark, Adriana H Tremoulet, Jennifer Le, Michael Cohen-Wolkowiez, P Brian Smith, Daniel K Benjamin, Best Pharmaceuticals for Children Act – Pediatric Trials Network

Open access · greenAbstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jessica E EricsonFrom the Department of Pediatrics, Penn State College of Medicine, Hershey, Pennsylvania.
Christoph P HornikDepartment of Pediatrics, Duke University, Durham, North Carolina.
Rachel G GreenbergDepartment of Pediatrics, Duke University, Durham, North Carolina.
Reese H ClarkPediatrix-Obstetrix Center for Research and Education, Sunrise, Florida.
Adriana H TremouletDepartment of Pediatrics, University of California, San Diego, La Jolla, California.
Jennifer LeSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, California.
Michael Cohen-WolkowiezDepartment of Pediatrics, Duke University, Durham, North Carolina.
P Brian SmithDepartment of Pediatrics, Duke University, Durham, North Carolina.
Daniel K BenjaminDepartment of Pediatrics, Duke University, Durham, North Carolina.
Best Pharmaceuticals for Children Act – Pediatric Trials Network
Duke University · USClinical Research Institute · USPenn State Milton S. Hershey Medical Center · USUniversity of California, San Diego · USUniversity of Montana · US

Funding

Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
Penn State Institutional Career Development CoreKL2TR002015 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI VAN SCOY, LAUREN JODI · 2016 to 2025
$7.8M
NCATS NIH HHS KL2 TR002015NCATS NIH HHS UL1 TR002014
6 · The paper itself

Abstract

backgroundHigh doses of ampicillin are often used to achieve therapeutic drug concentrations in infants. A paradoxical antibiotic effect, often called the Eagle effect, occurs when increasing concentrations of antibiotic above a threshold results in decreased efficacy. It is unknown if infants treated with ampicillin are at risk for this paradoxical effect.

methodsWe identified infants <28 days of age with Escherichia coli, Enterococcus or Streptococcus agalactiae (group B streptococcus) bloodstream infections from 1997 to 2012 and previously included in an ampicillin pharmacokinetic (PK) modeling study. We compared the odds of death for ampicillin dose, estimated time above the minimum inhibitory concentration (T > MIC) and PK parameters using separate logistic regression models. Adjusted logistic regression and Poisson models were used to calculate the odds of prolonged bacteremia ≥3 days and the duration of bacteremia, respectively, for dose, T > MIC and multiple PK parameters.

resultsAmong 1272 infants meeting inclusion criteria, odds of death 7 or 30 days after the positive blood culture were not consistent with a paradoxical effect across any of the dosing regimens or PK parameters evaluated. The odds of prolonged bacteremia was lowest at the lowest dose category and the lowest daily dose category but not associated with the area-under-the-concentration time curve from 0 to 24 hours, or the maximum or minimum concentrations at steady state. T > MIC of ≥50% of the dosing interval was associated with decreased duration of bacteremia and odds of prolonged bacteremia.

conclusionsIt is unlikely that a paradoxical antibiotic effect will have a clinical correlate when ampicillin is used for neonatal bacteremia. A T > MIC ≥50% decreased both duration of bacteremia and odds of prolonged bacteremia.

Indexed as

Dose-Response Relationship, DrugAmpicillinAnti-Bacterial AgentsBacteremiaFemaleGestational AgeHumansInfant, NewbornLogistic ModelsMaleMicrobial Sensitivity TestsModels, TheoreticalPoisson DistributionAmpicillinAnti-Bacterial Agents

Identifiers

PMID32235247
PMCPMC8628496
OpenAlexW3014372315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.